Click Chemistry-Mediated Synthesis, Spectroscopic Characterization, and Antimicrobial Evaluation of a Benzyl-Substituted 1,2,3-Triazole
DOI:
https://doi.org/10.33003/fjs-2026-1017-5904Keywords:
1,2,3-Triazole, Click Chemistry, Antimicrobial Activity, Minimum Inhibitory Concentration, Activity Index, Heterocyclic CompoundsAbstract
The increasing prevalence of antimicrobial resistance has intensified the search for new compounds with improved biological activity. In this study, 1,2,3-triazole derivative, 1-benzyl-4-((4-nitrophenoxy)methyl)-1H-1,2,3-triazole (PNT), was synthesized via a copper(I)-catalyzed azide–alkyne cycloaddition (CuAAC) reaction and characterized using Fourier-transform infrared spectroscopy (FTIR), ultraviolet-visible (UV–Vis) spectroscopy, 1H and 13C nuclear magnetic resonance (NMR) spectroscopy, and high-resolution mass spectrometry (HRMS). The antimicrobial potential of PNT was evaluated against six bacterial (Staphylococcus aureus, Streptococcus pyogenes, Streptococcus faecalis, Escherichia coli, Salmonella typhi, and Klebsiella pneumoniae) and two fungal (Candida albicans and Aspergillus fumigatus) strains using the agar well diffusion method, followed by determination of the minimum inhibitory concentration (MIC), minimum bactericidal concentration (MBC), and minimum fungicidal concentration (MFC). The compound exhibited concentration-dependent antimicrobial activity, with the largest inhibition zone observed against Klebsiella pneumoniae (18.00 ± 0.26 mm at 100 μg/mL), while Aspergillus fumigatus was the most susceptible fungal isolate (17.00 ± 0.56 mm). MIC/MBC values of 1.56 μg/mL were obtained against Staphylococcus aureus, whereas MIC/MFC values of 1.56 μg/mL were recorded for Aspergillus fumigatus, indicating bactericidal and fungicidal activities at the inhibitory concentration. Activity index analysis further demonstrated appreciable relative antimicrobial efficacy, with values of 44.0% and 43.5% against Aspergillus fumigatus and Staphylococcus aureus, respectively. The observed antimicrobial activity is attributed to the synergistic contribution of the 1,2,3-triazole nucleus, benzyl substituent, and electron-withdrawing nitrophenoxy moiety, which provide a promising pharmacophoric framework. These findings identify PNT as a promising lead compound for the development of new triazole-based antimicrobial agents and warrant further structural optimization and mechanistic investigations.
References
Abreu, S. T., Gelves, L. G. V., Barreiro, E. J., & Lima, L. M. (2024). Revisiting nitroaromatic drugs: mechanisms of bioactivation, metabolism and toxicity and methods to synthesize nitroaromatic fragments. Journal of the Brazilian Chemical Society, 35(10), e-20240071.
Agarwal, A., Singh, V., Maurya, A., Kumar, S., & Joshi, G. (2025). Design, synthesis, and antimicrobial evaluation of new triazole-tethered tetrazole hybrids via DNA gyrase inhibition. Scientific Reports, 15(1), 34695.
Ahmad, R., Li, M., & Tong, Y. (2026). Emergence, evolution, and global dissemination of antimicrobial resistance: A One Health review. Archives of Microbiology, 208(9), 447.
Ahmed, S. K., Hussein, S., Qurbani, K., Ibrahim, R. H., Fareeq, A., Mahmood, K. A., & Mohamed, M. G. (2024). Antimicrobial resistance: Impacts, challenges, and future prospects. Journal of Medicine, Surgery, and Public Health, 2, 100081.
Akinwumi, I. A., & Ambali, O. A. (2026). Exploring synergistic effects of bioactive compounds and pharmaceuticals in therapeutic applications. Journal of Holistic Integrative Pharmacy, 7(1), 102-110.
Armengol, E. S., Harmanci, M., & Laffleur, F. (2021). Current strategies to determine antifungal and antimicrobial activity of natural compounds. Microbiological research, 252, 126867.
Bhatia, S., Biharee, A., Mondal, S., Kulkarni, S., Kumar, R., & Thareja, S. (2025). Mechanistic analysis of diverse click reactions along with their applications. European Journal of Medicinal Chemistry, 296, 117800.
Bonandi, E., Christodoulou, M. S., Fumagalli, G., Perdicchia, D., Rastelli, G., & Passarella, D. (2017). The 1, 2, 3-triazole ring as a bioisostere in medicinal chemistry. Drug Discovery Today, 22(10), 1572-1581.
Bozorov, K., Zhao, J., & Aisa, H. A. (2019). 1, 2, 3-Triazole-containing hybrids as leads in medicinal chemistry: A recent overview. Bioorganic & medicinal chemistry, 27(16), 3511-3531.
Campana, F., Lanari, D., & Vaccaro, L. (2026). Clicking the sustainability: Nobel-awarded copper catalysed azide-alkyne cycloadditions (CuAAC) through Life Cycle Assessments analysis. Green Chemistry, 28(25), 10459-10471.
Dar, B. A., Bhat, A. R., Ahmed, S., Sheikh, F. A., Jamalis, J., Kawsar, S. M., Sheikh, S. A., Patil, R. C., & Abu-Rayyan, A. (2025). Pharmacological potential and in silico studies of triazole derivatives: A comprehensive review. In Silico Research in Biomedicine, 100094.
Dixit, D., Verma, P. K., & Marwaha, R. K. (2021). A review on ‘triazoles’: Their chemistry, synthesis and pharmacological potentials. Journal of the Iranian Chemical Society, 18(10), 2535-2565.
El Malah, T., Abdel Mageid, R. E., Awad, H. M., & Nour, H. F. (2020). Copper (i)-catalysed azide–alkyne cycloaddition and antiproliferative activity of mono-and bis-1, 2, 3-triazole derivatives. New Journal of Chemistry, 44(42), 18256-18263.
George, N., Singh, G., Singh, R., Singh, G., Singh, H., Kaur, G., & Singh, J. (2023a). Click modified bis-appended Schiff base 1, 2, 3-triazole chemosensor for detection of Pb (II) ion and computational studies. Journal of Molecular Structure, 1288, 135666.
George, N., Singh, G., Singh, R., Singh, G., Singh, H., Kaur, G., & Singh, J. (2023b). Schiff base functionalized 1, 2, 3-triazole derivative for Fe (III) ion recognition, as N, O, O-Fe-O, O, N sandwich complex: DFT analysis. Polyhedron, 242, 116496.
Gow, N. A. (2025). Fungal cell wall biogenesis: structural complexity, regulation and inhibition. Fungal Genetics and Biology, 179, 103991.
Grady, E. N., MacDonald, J., Liu, L., Richman, A., & Yuan, Z.-C. (2016). Current knowledge and perspectives of Paenibacillus: a review. Microbial cell factories, 15(1), 203.
Ibisanmi, T. A., Jiang, X., Willcox, M., & Kumar, N. (2026). Recent advances in computational antimicrobial peptide discovery through big data, modeling, and artificial intelligence and their interplay in ushering the next golden era of drug development. Frontiers in Bioinformatics, 6, 1749404.
Jaber, A., Bitar, L., & Jaber, A. (2025). The role of nitro groups in pharmaceuticals: Effects and interactions with biological systems. Artic. Afr. J. Pharm. Sci, 5, 1-7.
Kaur, J., Saxena, M., & Rishi, N. (2021). An overview of recent advances in biomedical applications of click chemistry. Bioconjugate chemistry, 32(8), 1455-1471.
Kukov, D., Dronov, A., Frolova, M., Afanasyeva, I., & Chernykh, I. (2025). Prospects for Using 1, 2, 3-Triazole Derivatives in Medicinal Chemistry. Pharmaceutical Chemistry Journal, 59(3), 285-295.
Lengerli, D., Ibis, K., Nural, Y., & Banoglu, E. (2022). The 1, 2, 3-triazole ‘all-in-one’ring system in drug discovery: A good bioisostere, a good pharmacophore, a good linker, and a versatile synthetic tool. Expert Opinion on Drug Discovery, 17(11), 1209-1236.
Lionetti, D., Day, V. W., & Blakemore, J. D. (2017). Noncovalent immobilization and surface characterization of lanthanide complexes on carbon electrodes. Dalton Transactions, 46(35), 11779-11789.
Lu, X., Zhou, J., Ming, Y., Wang, Y., He, R., Li, Y., Feng, L., Zeng, B., Du, Y., & Wang, C. (2025). Next-generation antifungal drugs: Mechanisms, efficacy, and clinical prospects. Acta Pharmaceutica Sinica B.
Lucero-Prisno III, D. E., Okesanya, O. J., Agboola, A. O., Adebayo, U. O., Adigun, O. A., Ahmed, M. M., Olaleke, N. O., Oso, T. A., Tan, M. I. R. S., & Ogaya, J. B. (2025). Emerging technologies and innovative approaches to combat antimicrobial resistance: A narrative review of next-generation therapeutic strategies. Next Bioengineering, 1, 100003.
Majumder, S., & Panigrahi, G. K. (2025). Advancements in contemporary pharmacological innovation: mechanistic insights and emerging trends in drug discovery and development. Intelligent Pharmacy, 3(2), 118-126.
Martis, G. J., Maiya, S., & Gaonkar, S. L. (2025). Synthetic Developments and Biological Insights of 1, 2, 3-Triazoles: Unravelling Scope for Drug Discovery. European Journal of Medicinal Chemistry Reports, 100315.
Oprea, I., & Smith, T. K. (2024). Click chemistry methodology: the novel paintbrush of drug design. ACS Chemical Biology, 20(1), 19-32.
Pal, R., Chakraborty, J., Mukhopadhyay, T. K., Kanungo, A., Saha, R., Chakraborty, A., Patra, D., Datta, A., & Dutta, S. (2022). Substituent effect of benzyl moiety in nitroquinoxaline small molecules upon DNA binding: cumulative destacking of DNA nucleobases leading to histone eviction. European Journal of Medicinal Chemistry, 229, 113995.
Şahin, İ. (2022). Synthesis And Characterization Of Schiff Bases Containing 1, 2, 3-Triazole Unit: Photophysical And Acetyl Choline (Ache) Inhibitory Properties. Journal of Structural Chemistry, 63(11), 1787-1796.
Salma, U., Alam, M. Z., Ahmad, S., Mohasin, M., & Khan, S. A. (2025). A comprehensive review on recent advances of remarkable scaffold Triazole based schiff base: synthesis and photoresponsive chemosensors for Al3+ ion detection. Journal of Fluorescence, 35(10), 9531-9551.
Sharma, A., Dubey, R., Bhupal, R., Patel, P., Verma, S. K., Kaya, S., & Asati, V. (2023). An insight on medicinal attributes of 1, 2, 3‐and 1, 2, 4‐triazole derivatives as alpha-amylase and alpha-glucosidase inhibitors. Molecular Diversity, 1-30.
Singh, G., Majeed, A., Singh, R., George, N., Singh, G., Gupta, S., Singh, H., Kaur, G., & Singh, J. (2023). CuAAC ensembled 1, 2, 3-triazole linked nanogels for targeted drug delivery: A review. RSC advances, 13(5), 2912-2936.
Singh, G., Priyanka, Sushma, Diksha, Mohit, Suman, Kaur, J. D., Saini, A., & Satija, P. (2021). Design, synthesis and photophysical aspects of 1, 2, 3-triazole appended Schiff base functionalized silanes and silatranes. New Journal of Chemistry, 45(37), 17356-17365.
Teixeira, M. M., Carvalho, D. T., Sousa, E., & Pinto, E. (2022). New antifungal agents with azole moieties. Pharmaceuticals, 15(11), 1427.
Tiwari, V. K., Jaiswal, M. K., Rajkhowa, S., & Singh, S. K. (2024). CuAAC ‘Click Chemistry’-Mediated Synthesis of 1, 4-Disubstituted 1, 2, 3-Triazoles. In Click Chemistry (pp. 43-81). Springer.
Urbin, S. S., Casey, H., Price, A. P., LaBauve, A. E., & Fisher, C. L. (2025). Novel Disk diffusion Assay for Filamentous Fungi Susceptibility to antifungals (DAFFS). Journal of Microbiological Methods, 235, 107145.
Vaishnani, M. J., Bijani, S., Rahamathulla, M., Baldaniya, L., Jain, V., Thajudeen, K. Y., Ahmed, M. M., Farhana, S. A., & Pasha, I. (2024). Biological importance and synthesis of 1, 2, 3-triazole derivatives: a review. Green Chemistry Letters and Reviews, 17(1), 2307989.
Vala, D. P., Parmar, M. P., & Patel, H. M. (2026). Electrochemically driven azide–alkyne cycloaddition (E-CuAAC) via anodic oxidation using dual copper electrodes. Green Chemistry, 28(6), 2724-2735.
Wiegand, I., Hilpert, K., & Hancock, R. E. (2008). Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances. Nature protocols, 3(2), 163-175.
Downloads
Published
Issue
Section
Categories
License
Copyright (c) 2026 Grema A. Mala, Ibrahim M. Wakil, Abubakar A. Ahmed, Hauwa A. Zarma, Hassan I. Musa, Ibrahim Waziri
This work is licensed under a Creative Commons Attribution 4.0 International License.
